Enhancing Supply Chain Resilience in Pharmaceuticals Amid Tariffs and Disruptions
This analysis explores the operational strategies drug manufacturers and distributors can adopt to bolster supply chain resilience in the face of tariffs and disruptions.
The pharmaceutical supply chain is increasingly affected by tariffs, which can significantly impact drug pricing and availability. Understanding these effects is crucial for stakeholders.
Key disruptions in the supply chain include geopolitical factors, regulatory changes, and logistical challenges. Identifying these disruptions allows companies to prepare and adapt effectively.
Implementing operational resilience strategies is essential for drug manufacturers and distributors. This includes diversifying suppliers, enhancing inventory management, and investing in technology to streamline processes.